Current Disease Management of Primary Urethral Carcinoma.
Janisch F, Abufaraj M, Fajkovic H, Kimura S, Iwata T, Nyirady P, Rink M, Shariat SF.
Eur Urol Focus. 2019 Sep;5(5):722-734. doi: 10.1016/j.euf.2019.07.001. Epub 2019 Jul 13.
Management of Urethral Hemangioma.
Alam R, Rostom M, Cohen AJ.
Urology. 2022 Feb;160:227. doi: 10.1016/j.urology.2021.10.027. Epub 2021 Nov 13.
The effect of holmium laser resection versus standard transurethral resection on non-muscle-invasive bladder cancer: a systematic review and meta-analysis.
Li C, Gao L, Zhang J, Yang X, Liu C.
Lasers Med Sci. 2020 Jul;35(5):1025-1034. doi: 10.1007/s10103-020-02972-w. Epub 2020 Jan 31.
Risk factors for bladder neck contracture after transurethral resection of the prostate.
Goßler C, Pfänder F, Haas M, Mayr R, Gierth M, Burger M, Rosenhammer B, Breyer J.
Prostate. 2023 Aug;83(11):1020-1027. doi: 10.1002/pros.24543. Epub 2023 Apr 23.
The Impact of En-bloc Transurethral Resection of Bladder Tumour on Clinical, Pathological and Oncological Outcomes: A Cohort Study.
Kannan D, Sekaran PG, Sankaran S, Taur P, J SP, Paul R, Thangarasu M, Jain N.
Cureus. 2023 Jul 26;15(7):e42523. doi: 10.7759/cureus.42523. eCollection 2023 Jul.
Urinary morbidity and incontinence following transurethral resection of the prostate after brachytherapy.
Kollmeier MA, Stock RG, Cesaretti J, Stone NN.
J Urol. 2005 Mar;173(3):808-12. doi: 10.1097/01.ju.0000152698.20487.0e.
Bladder perforation as a complication of transurethral resection of bladder tumors: the predictors, management, and its impact in a series of 1570 at a tertiary urology institute.
Osman Y, Elawdy M, Taha DE, Zahran MH, Abouelkheir RT, Sharaf DE, Mosbah A, Ali-El Dein B.
Int Urol Nephrol. 2023 Sep;55(9):2161-2167. doi: 10.1007/s11255-023-03638-6. Epub 2023 Jun 15.
Transurethral resection in the management of urethral and prostatic neoplasia in 6 dogs.
Liptak JM, Brutscher SP, Monnet E, Dernell WS, Twedt DC, Kazmierski KJ, Walter CU, Mullins MN, Larue SM, Withrow SJ.
Vet Surg. 2004 Sep-Oct;33(5):505-16. doi: 10.1111/j.1532-950x.2004.04067.x.
Primary Chemoablation of Recurrent Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer With UGN-102: A Single-Arm, Open-Label, Phase 3 Trial (ENVISION).
Prasad SM, Shishkov D, Mihaylov NV, Khuskivadze A, Genov P, Terzi V, Kates M, Huang WC, Louie MJ, Raju S, Burger B, Meads A, Schoenberg M.
J Urol. 2025 Feb;213(2):205-216. doi: 10.1097/JU.0000000000004296. Epub 2024 Oct 24.
Simultaneous transurethral resection of bladder tumour and prostate: is it safe?
Kouriefs C, Loizides S, Mufti G.
Urol Int. 2008;81(2):125-8. doi: 10.1159/000144048. Epub 2008 Aug 29.
